Published studies show improved immunogenicity of PharmaJet System for DNA vaccines GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a biotech company that, with their innovative needle-free technology, has developed a more effective way of administering drugs and biologics to accelerate research, commercialization and public health outcomes, announced that its partner, Scancell, will include needle-free delivery of their Phase 2 … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a next-generation digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, today announced the first patient save from a successful defibrillation early in the enrollment of the Investigational Device Exception (IDE) Study of its Jewel Patch Wearable Cardioverter Defibrillator (P-WCD). The Jewel … [Read more…]

Appointments support accelerated growth of proprietary mesh technology ST. PAUL, Minn.–(BUSINESS WIRE)–Spineology Inc., the longtime leader in ultra-minimally invasive spine surgery, announces the promotion of Matt Cronin to Chief Commercial Officer. Cronin will lead Spineology’s commercial team of sales, marketing and medical education, driving the company’s commercial strategy. “Having worked with Matt the last year … [Read more…]

JACKSONVILLE, Ill.–(BUSINESS WIRE)–Turner Scientific, a world leader in laboratory monitoring and nonclinical hearing research, is pleased to announce that Cindy Buckmaster, Ph.D., has joined its laboratory monitoring team as Chief Operating Officer of Facility Monitoring Services. Dr. Buckmaster was previously the Director of the Center for Comparative Medicine at Baylor College of Medicine and is … [Read more…]

Researchers to highlight positive results from a phase 3 clinical study for treatment of agitation in patients with Alzheimer’s dementia PRINCETON, N.J. & DEERFIELD, Ill.–(BUSINESS WIRE)–Otsuka Pharmaceutical Development & Commercialization, Inc., and H. Lundbeck A/S (Lundbeck) today announce that new Phase 3 data for brexpiprazole will be presented at the 2022 Alzheimer’s Association International Conference … [Read more…]

LEXINGTON, Ky.–(BUSINESS WIRE)–OmniLife, a SaaS health technology integrated communication and care coordination platform for the organ transplantation and organ failure care continuum, has named Matt Stafford as Senior Vice President of Sales. He will lead the company’s aggressive growth strategy to expand customer networks throughout the United States. Stafford brings over 15 years of Healthcare … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–CHA Hollywood Presbyterian Medical Center (CHA HPMC) has launched telestroke services to provide timely assessment of stroke and improve the quality of care to its patients through a collaboration with the USC TeleStroke and Neurological Emergency Program. This program allows physicians in the emergency room at CHA HPMC to consult directly with Keck … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Minnesota Health Market Review 2022” report has been added to ResearchAndMarkets.com’s offering. National health insurers are grabbing more market share in Minnesota, and some Minnesota companies are expanding outside the state. HMOs increased their enrollment by 8.5% in 2021, adding Medicaid and Medicare beneficiaries and, despite higher medical expenses, they generally maintained their … [Read more…]

The next-generation Definium™ 656 HD, featuring in-room workflows, motorization and the Intelligent Workflow Suite, assists technologists with patient positioning and technique selection to reduce physical workload and improve overall efficiency to make the first image count and maximize a technologist’s time with patients. A combination of FlashPad™ detectors, advanced image creation applications, and the latest … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “RWE Oncology Market by Component, Application, End User – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The RWE oncology solutions market is expected to grow at a CAGR of 14.2% from 2022-2029 to reach $1.65 billion by 2029. After a comprehensive primary and secondary research and an in-depth analysis … [Read more…]